NYSE:VTR · New York Stock Exchange
-$0.28 today
Vol 1.72M · Avg 4.09M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Management quality matters because capital allocation choices determine how much of Ventas, Inc. earnings power becomes long-term shareholder value. Use this page to compare VTR returns on capital, executive context, insider transactions, ownership signals, and growth trends against peers, then decide whether leadership appears disciplined, aligned, and capable of compounding through changing market conditions.
Return Metrics
ROE, ROIC & ROA over time
ROE
2.0%
avg 3.4%
ROIC
3.2%
avg 2.7%
ROA
0.9%
avg 1.5%
Analysis
ROIC is currently the strongest return metric at 3.2% versus its period average of 2.7%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Debra A. Cafaro | Chairman & Chief Executive Officer | $5.49M | — | 68 | $1.29M | 0.27% |
Robert F. Probst | Executive Vice President & Chief Financial Officer | $2.54M | — | 58 | $169,759.00 | 0.03% |
James Justin Hutchens | Executive Vice President of Senior Housing & Chief Investment Officer | $2.49M | — | 52 | $200,573.00 | 0.04% |
T. Richard Riney | Senior Advisor | $1.85M | — | 68 | $41,209.58 | <0.01% |
Carey Shea Roberts | Executive Vice President, General Counsel, Corporate Secretary and Ethics & Compliance Officer | $1.79M | — | 55 | $72,755.00 | 0.01% |
Peter J. Bulgarelli | Executive Vice President of Outpatient Medical & Research | $1.67M | — | 66 | $124,422.00 | 0.03% |
Timothy Sanders | Senior Vice President of Business Development | — | — | — | — | — |
Bhavana Devulapally | Senior Vice President & Chief Information Officer | — | — | — | — | — |
Alex Russo | Senior Managing Director of Investments | — | — | — | — | — |
Bill Grant | Senior Vice President of Investor Relations | — | — | — | — | — |
Brian K. Wood | Chief Tax Officer & Senior Vice President | — | — | — | — | — |
Christian N. Cummings | Senior Vice President of Asset Management - Seniors Housing | — | — | 52 | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
1
$197,025.00
Sells
37
$52.55M
Net Sentiment
$52.35M
Net selling
Most Active
CAFARO DEBRA A
20 transactions
1–10 of 38
Analysis
Insiders reported 1 buys worth $197,025.00 and 37 sells worth $52.55M over the last 12 months. That adds up to net selling of $52.35M. CAFARO DEBRA A was the most active insider with 20 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +0.5% | +2.9% (14yr)1 analysts |
| Revenue | N/A | N/A | +9.8% | +7.2% (14yr)3 analysts |
| Net Income | N/A | N/A | +4.8% | +5.3% (14yr)3 analysts |
| EBIT | N/A | N/A | +6.4% | +1.9% (14yr)3 analysts |
Analysis
Recent growth has been strongest in Revenue at +9.8% over three years. Forward estimates point to Revenue at +7.2% (14yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Iron Mountain Incorporated
NYSE:IRM
$34.86B
Crown Castle Inc.
NYSE:CCI
$33.43B
Extra Space Storage Inc.
NYSE:EXR
$31.54B
VICI Properties Inc.
NYSE:VICI
$29.06B
AvalonBay Communities, Inc.
NYSE:AVB
$27.52B
Equity Residential
NYSE:EQR
$26.16B
SBA Communications Corporation
NASDAQ:SBAC
$19.57B
Healthpeak Properties, Inc.
NYSE:DOC
$15.09B
Omega Healthcare Investors, Inc.
NYSE:OHI
$14.71B
CoStar Group, Inc.
NASDAQ:CSGP
$12.25B
Who manages VTR?
Ventas, Inc. (VTR) lists 12 active executives. The top listed executive is Peter J. Bulgarelli, Executive Vice President of Outpatient Medical & Research.
Are VTR insiders buying or selling?
Recent insider activity shows net selling of $57.66M.
Explore More
Continue the stock analysis
Jump to another research area for this company.